Cognition Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGTX and other ETFs, options, and stocks.About CGTX
Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions.
CGTX Key Statistics
Stock Snapshot
As of today, Cognition Therapeutics(CGTX) shares are valued at $1.09. The company's market cap stands at 95.78M, with a P/E ratio of -2.23.
On 2026-03-05, Cognition Therapeutics(CGTX) stock traded between a low of $1.06 and a high of $1.09. Shares are currently priced at $1.09, which is +2.4% above the low and -0.5% below the high.
The Cognition Therapeutics(CGTX)'s current trading volume is 114.24K, compared to an average daily volume of 663.42K.
In the last year, Cognition Therapeutics(CGTX) shares hit a 52-week high of $3.83 and a 52-week low of $0.22.
In the last year, Cognition Therapeutics(CGTX) shares hit a 52-week high of $3.83 and a 52-week low of $0.22.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.